Manage the
business of science.
Manage the
business of science.
Manage the
business of science.
Orchestra helps R&D organizations reduce the operational complexity of drug development

Q2 2025 board meeting
Base case
Sources
Tables
Charts
Base case
cash out
Feb 2026
Sep 2026
total burn
$30,247,923
$26,963,436
average monthly burn
$772,219
$691,370
ending cash
$17,482,592
$14,509,558
H1 2025
H2 2025
H1 2026
H2 2026
H1 2027
H2 2027
Antibody program 001
Lead ID
🎯
DC Selection
🥇
Stable pools
🧬
Go for GLP Tox
🐭
Go for GMP
🏭
IND
🏛️
Go to Phase 1
💉
Antibody program 004
Phase 1 Acceleration
Go for GMP
🏭
Comparability done
🐭
IND
🏛️
-3 months
Go to Phase 1
💉
-3 months
End of Phase 1
🏥
-3 months
Finances
$25M
$20M
$15M
$10M
Last actual
Cash out
Base case: Projected cash balance
Base scenario: Cumulative spend
TODAY
Q2 2025 board meeting
Base case
Sources
Tables
Charts
Base case
cash out
Feb 2026
Sep 2026
total burn
$30,247,923
$26,963,436
average monthly burn
$772,219
$691,370
ending cash
$17,482,592
$14,509,558
H1 2025
H2 2025
H1 2026
H2 2026
H1 2027
H2 2027
Antibody program 001
Lead ID
🎯
DC Selection
🥇
Stable pools
🧬
Go for GLP Tox
🐭
Go for GMP
🏭
IND
🏛️
Go to Phase 1
💉
Antibody program 004
Phase 1 Acceleration
Go for GMP
🏭
Comparability done
🐭
IND
🏛️
-3 months
Go to Phase 1
💉
-3 months
End of Phase 1
🏥
-3 months
Finances
$25M
$20M
$15M
$10M
Last actual
Cash out
Base case: Projected cash balance
Base scenario: Cumulative spend
TODAY
Q2 2025 board meeting
Base case
Sources
Tables
Charts
Base case
cash out
Feb 2026
Sep 2026
total burn
$30,247,923
$26,963,436
average monthly burn
$772,219
$691,370
ending cash
$17,482,592
$14,509,558
H1 2025
H2 2025
H1 2026
H2 2026
H1 2027
H2 2027
Antibody program 001
Lead ID
🎯
DC Selection
🥇
Stable pools
🧬
Go for GLP Tox
🐭
Go for GMP
🏭
IND
🏛️
Go to Phase 1
💉
Antibody program 004
Phase 1 Acceleration
Go for GMP
🏭
Comparability done
🐭
IND
🏛️
-3 months
Go to Phase 1
💉
-3 months
End of Phase 1
🏥
-3 months
Finances
$25M
$20M
$15M
$10M
Last actual
Cash out
Base case: Projected cash balance
Base scenario: Cumulative spend
TODAY
Align your organization from bench to boardroom
R&D Planning
Build a centralized roadmap across leadership, programs, and scientific groups
Financial Modelling







01
Unified Planning
02
intelligent operations
03
Decision Support
01
Unified Planning
Align your organization from bench to boardroom
R&D Planning
Build a centralized roadmap across leadership, programs, and scientific groups


02
intelligent operations
Automatically track progress, risks, and outcomes
AI-Powered Progress & Risk Tracking
Get to ground truth by interpreting meetings, documents, and reports


03
Decision Support
Plans change. Plan for that too.
01
Unified Planning
Align your organization from bench to boardroom
R&D Planning
Build a centralized roadmap across leadership, programs, and scientific groups


02
intelligent operations
Automatically track progress, risks, and outcomes
AI-Powered Progress & Risk Tracking
Get to ground truth by interpreting meetings, documents, and reports


03
Decision Support
